4//SEC Filing
Molineaux Christopher P. 4
Accession 0001415889-25-016247
CIK 0001557746other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:20 PM ET
Size
11.9 KB
Accession
0001415889-25-016247
Insider Transaction Report
Form 4
Molineaux Christopher P.
Director
Transactions
- Award
Restricted Stock Units
2025-06-05+11,580→ 11,580 total→ Common Stock (11,580 underlying) - Exercise/Conversion
Common Stock
2025-06-06+4,793→ 57,956 total - Award
Stock Option (Right to Buy)
2025-06-05+42,350→ 42,350 totalExercise: $1.56Exp: 2035-06-04→ Common Stock (42,350 underlying) - Exercise/Conversion
Restricted Stock Units
2025-06-06−4,793→ 0 total→ Common Stock (4,793 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares subject to this stock option will vest in twelve equal monthly installments commencing on July 5, 2025, subject to the Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date.
- [F3]This grant was made pursuant to the issuer's tenth amended and restated non-employee director compensation policy.
- [F4]The shares underlying these restricted stock units will vest in one installment on June 5, 2026, subject to the Reporting Person's Continuous Service (as defined in the Plan) as of such date.
- [F5]The shares underlying these restricted stock units vested on June 6, 2025.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654773
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:20 PM ET
- Size
- 11.9 KB